Ausgabe 3/2015
Including PIH Article on Molecular pathogenesis and treatment strategies of adult leukemia
Inhalt (14 Artikel)
Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma
Nuri Yigit, William W. Wu, Shannon Covey, Wayne Tam
Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms
Bhumika Patel, Cassandra Hirsch, Michael Clemente, Mikkael Sekeres, Hideki Makishima, Jaroslaw P. Maciejewski
Molecular pathogenesis of CLL and its evolution
David Rodríguez, Gabriel Bretones, Javier R. Arango, Víctor Valdespino, Elías Campo, Víctor Quesada, Carlos López-Otín
Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable
Katerina Zoi, Nicholas C. P. Cross
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective
Masamitsu Yanada
Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
David J. Kuter, Cynthia Macahilig, Kelly M. Grotzinger, Sara A. Poston, Peter Feng Wang, Katie L. Dawson, Melea Ward
The Effect of Preoperative Vitamin K on the INR in Bridging Therapy
Ashrei Bayewitz, Barbara Scorziello, Clarice Maala, Emily Giannattasio, Henny Heisler Billett
Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients
Akihisa Nagata, Naohiro Sekiguchi, Miwa Kurimoto, Satoshi Noto, Naoki Takezako
Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea
Moon Jin Kim, Min Eui Hong, Chi Hoon Maeng, Hyun Ae Jung, Jung Yong Hong, Moon Ki Choi, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim
Long-term follow-up of homoharringtonine plus all-trans retinoic acid-based induction and consolidation therapy in newly diagnosed acute promyelocytic leukemia
Ying Wang, Dong Lin, Hui Wei, Wei Li, Bingcheng Liu, Chunlin Zhou, Kaiqi Liu, Yingchang Mi, Jianxiang Wang
Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma
Kenshi Suzuki, Michinori Ogura, Yu Abe, Tatsuya Suzuki, Kensei Tobinai, Kiyoshi Ando, Masafumi Taniwaki, Dai Maruyama, Minoru Kojima, Junya Kuroda, Meguru Achira, Koho Iizuka
A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis
Kenji Oritani, Shinichiro Okamoto, Tetsuzo Tauchi, Shigeki Saito, Kohshi Ohishi, Hiroshi Handa, Katsuto Takenaka, Prashanth Gopalakrishna, Taro Amagasaki, Kazuo Ito, Koichi Akashi
Mutations in Bruton’s tyrosine kinase impair IgA responses
Noriko Mitsuiki, Xi Yang, Sophinus J. W. Bartol, Christina Grosserichter-Wagener, Yoshiyuki Kosaka, Hidetoshi Takada, Kohsuke Imai, Hirokazu Kanegane, Shuki Mizutani, Mirjam van der Burg, Menno C. van Zelm, Osamu Ohara, Tomohiro Morio